These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 28052654)

  • 1. Postmastectomy Radiotherapy in Patients with pT1-2N1 Breast Cancer Treated with Taxane-Based Chemotherapy: A Retrospective Multicenter Analysis (KROG 1418).
    Kim YJ; Park W; Ha B; Park B; Joo J; Kim TH; Park IH; Lee KS; Lee ES; Shin KH; Kim H; Yu JI; Choi DH; Huh SJ; Wee CW; Kim K; Park KR; Kim YB; Ahn SJ; Lee JH; Kim JH; Chun M; Lee HS; Kim JS; Cha J
    Cancer Res Treat; 2017 Oct; 49(4):927-936. PubMed ID: 28052654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Risk-adapted postmastectomy radiotherapy based on local-regional recurrence for T1-2N1M0 breast Cancer].
    Li M; Wang SL; Fang H; Tang Y; Chen B; Qi SN; Song YW; Liu YP; Lu NN; Li N; Tang Y; Ren H; Jin J; Li YX
    Zhonghua Zhong Liu Za Zhi; 2017 Nov; 39(11):841-849. PubMed ID: 29151291
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of postmastectomy radiation therapy after neoadjuvant chemotherapy in clinical stage II-III breast cancer patients with pN0: a multicenter, retrospective study (KROG 12-05).
    Shim SJ; Park W; Huh SJ; Choi DH; Shin KH; Lee NK; Suh CO; Keum KC; Kim YB; Ahn SD; Kim SS; Ha SW; Chie EK; Kim K; Shin HS; Kim JH; Lee HS
    Int J Radiat Oncol Biol Phys; 2014 Jan; 88(1):65-72. PubMed ID: 24161425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic differences and the effect of postmastectomy radiotherapy between post-chemotherapy ypT1-2ypN1 and de novo pT1-2N1 breast cancer.
    Yang T; Zhong X; Wang J; Xiang Z; Zeng Y; Yu S; Dai Z; Xu N; Luo T; Liu L
    Cancer Med; 2023 Apr; 12(7):8112-8121. PubMed ID: 36734308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Impact of Elective Supraclavicular Nodal Irradiation for Patients with N1 Breast Cancer after Lumpectomy and Anthracycline Plus Taxane-Based Chemotherapy (KROG 1418): A Multicenter Case-Controlled Study.
    Kim H; Park W; Yu JI; Choi DH; Huh SJ; Kim YJ; Lee ES; Lee KS; Kang HS; Park IH; Shin KH; Wee CW; Kim K; Park KR; Kim YB; Ahn SJ; Lee JH; Kim JH; Chun M; Lee HS; Kim JS; Cha J
    Cancer Res Treat; 2017 Oct; 49(4):970-980. PubMed ID: 28052649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postmastectomy radiotherapy in patients with T
    Luo M; Jin Y; Xu C; Chen H; Zhang K; Chen Q; Jin C; Lu J; Wang J; Huang J; Deng H; Jin W; Zheng S; Chen Y; Zhou J
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):9979-9990. PubMed ID: 37256383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of postmastectomy radiotherapy in clinical T1-3N1M0 breast cancer patients with pathological negative lymph nodes after neoadjuvant chemotherapy and mastectomy].
    Rong QL; Wang SL; Tang Y; Jin J; Song YW; Wang WH; Liu YP; Fang H; Ren H; Liu XF; Yu ZH; Li YX
    Zhonghua Zhong Liu Za Zhi; 2017 Jun; 39(6):445-452. PubMed ID: 28635235
    [No Abstract]   [Full Text] [Related]  

  • 8. Practical Model to Optimize the Strategy of Adjuvant Postmastectomy Radiotherapy in T1-2N1 Breast Cancer With Modern Systemic Therapy.
    Xu FF; Cao L; Xu C; Cai G; Wang SB; Qi WX; Chen JY
    Front Oncol; 2022; 12():789198. PubMed ID: 35280719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of clinical-pathological factors on locoregional recurrence in mastectomy patients with T1-2N1 breast cancer: who can omit adjuvant radiotherapy?
    Wang X; Zhang L; Zhang X; Luo J; Wang X; Chen X; Yang Z; Mei X; Yu X; Zhang Z; Guo X; Shao Z; Ma J
    Breast Cancer Res Treat; 2021 Nov; 190(2):277-286. PubMed ID: 34490502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of the AJCC 8th edition staging system for selecting patients with T1-2N1 breast cancer for post-mastectomy radiotherapy: a joint analysis of 1986 patients from two institutions.
    Wang S; Wen G; Tang Y; Yang Y; Jing H; Wang J; Zhang J; Zhao X; Sun G; Jin J; Song Y; Liu Y; Fang H; Zhang Y; Li Y
    BMC Cancer; 2020 Aug; 20(1):792. PubMed ID: 32838753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Postmastectomy Radiation Therapy on Breast Cancer Patients According to Pathologic Nodal Status after Modern Neoadjuvant Chemotherapy.
    Kim D; Kim JH; Kim IA; Chang JH; Shin KH
    Cancer Res Treat; 2023 Apr; 55(2):592-602. PubMed ID: 36228653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical value of adjuvant radiotherapy in patients with early stage breast cancer with 1 to 3 positive lymph nodes after mastectomy.
    Wu SG; He ZY; Li FY; Wang JJ; Guo J; Lin Q; Guan XX
    Chin J Cancer; 2010 Jul; 29(7):668-76. PubMed ID: 20591219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is it beneficial for patients with pT1-2N1M0 breast cancer to receive postmastectomy radiotherapy? An analysis based on RecurIndex assay.
    Zhang L; Zhou M; Liu Y; Du F; Tang J; Wang N; Song C; Geng C; Duan H
    Int J Cancer; 2021 Nov; 149(10):1801-1808. PubMed ID: 34224580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incorporating Risk Factors to Identify the Indication of Post-mastectomy Radiotherapy in N1 Breast Cancer Treated with Optimal Systemic Therapy: A Multicenter Analysis in Korea (KROG 14-23).
    Park HJ; Shin KH; Kim JH; Ahn SD; Kim JY; Park W; Kim YB; Kim YJ; Kim JH; Kim K; Park KR; Shin HS; Jeong BK; Lee SY; Kim S
    Cancer Res Treat; 2017 Jul; 49(3):739-747. PubMed ID: 27764904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of age as a continuous variable on the prognosis of patients with pT1-2N1 breast cancer.
    Zhao XR; Tang Y; Wu HF; Guo QS; Zhang YJ; Shi M; Cheng J; Wang HM; Liu M; Ma CY; Wen G; Wang XH; Fang H; Jing H; Song YW; Jin J; Liu YP; Chen B; Qi SN; Li N; Tang Y; Lu NN; Zhang N; Li YX; Wang SL
    Breast; 2022 Dec; 66():136-144. PubMed ID: 36270084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do Recent Advances in Diagnostic and Therapeutic Procedures Negate the Benefit of Postmastectomy Radiotherapy in N1 Patients With a Low Risk of Locoregional Recurrence?
    Chang JS; Lee J; Kim KH; Sohn JH; Kim SI; Park BW; Chung HC; Keum KC; Suh CO; Kim YB
    Medicine (Baltimore); 2015 Aug; 94(33):e1259. PubMed ID: 26287410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nomogram predicting survival as a selection criterion for postmastectomy radiotherapy in patients with T1 to T2 breast cancer with 1 to 3 positive lymph nodes.
    Tang Y; Zhang YJ; Zhang N; Shi M; Wen G; Cheng J; Wang HM; Liu M; Wang XH; Guo QS; Wu HF; Ma CY; Jin J; Liu YP; Song YW; Fang H; Ren H; Wang SL; Li YX
    Cancer; 2020 Aug; 126 Suppl 16():3857-3866. PubMed ID: 32710662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postmastectomy radiotherapy improves disease-free survival of high risk of locoregional recurrence breast cancer patients with T1-2 and 1 to 3 positive nodes.
    He ZY; Wu SG; Zhou J; Li FY; Lin Q; Lin HX; Sun JY
    PLoS One; 2015; 10(3):e0119105. PubMed ID: 25781605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors for breast cancer patients with T1-2 tumors and 1-3 positive lymph nodes and the role of postmastectomy radiotherapy in these patients.
    Zhao JM; An Q; Sun CN; Li YB; Qin ZL; Guo H; Zeng X; Zhang YT; Wei LL; Han N; Sun SC; Zhang N
    Breast Cancer; 2021 Mar; 28(2):298-306. PubMed ID: 32940902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of different lymph node staging systems in predicting prognosis and determining indications for postmastectomy radiotherapy in patients with T1-T2pN1 breast carcinoma.
    Kustić D; Klarica Gembić T; Grebić D; Petretić Majnarić S; Nekić J
    Strahlenther Onkol; 2020 Nov; 196(11):1044-1054. PubMed ID: 32710122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.